A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels

Clinical trial NCT05161936 · TERMINATED

Trial details

NCT number: NCT05161936
Sponsor: Alnylam Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Calcium Oxalate Kidney Stone Disease Elevated Urinary Oxalate Levels

Start date: 2022-01-27
Primary completion: 2022-11-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.